EVENTIDE ASSET MANAGEMENT, LLC

Q4 2019 13F-HR Holdings

Location
Boston, MA
Holdings as of
12/31/2019
Date filed
1/29/2020
Form type
13F-HR
Num holdings
116
Total value ($000)
$3,548,958
Net value change ($000)
—
New positions
110
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/13/2014 Next filing: 5/15/2020 SEC filing

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ASND 236,316 —
ZOGENIX, INC. 148,117 —
SRPT 128,524 —
TTD 110,407 —
Aimmune Therapeutics, Inc. 103,221 —
Biohaven Pharmaceutical Holding Co Ltd. 88,955 —
FIVN 81,975 —
TWLO 81,278 —
ROP 75,805 —
WCN 72,995 —
Top Reduces (Value $000, Stocks/ETFs)
—
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type